文献速递神经肿瘤

人脑胶质瘤中IDH1突变诱导的化学改变可通过光学拉曼光谱检测

IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy.
PubMed 文献 · J Neurooncol · 2018-05-14

研究纳入36例手术切除的人脑胶质瘤标本,制备冰冻切片,用DNA测序判定IDH1突变状态,每例样本采集100条拉曼光谱。结果显示IDH1突变型胶质瘤中与DNA相关的光谱带强度增加、与脂质分子振动相关的谱带显著降低,蛋白相关谱带强度也出现差异;选取498、826、1003、1174和1337 cm-1五个谱带可将拉曼光谱按IDH1基因型分类,正确率为89%。作者认为拉曼光谱是一种简单、快速且安全的IDH1突变检测方法,在临床相关原位诊断方面展现出很大前景。

要点

  • 36例人脑胶质瘤标本中,IDH1突变型与野生型拉曼光谱在DNA、脂质和蛋白相关谱带上存在差异。
  • 选取498、826、1003、1174和1337 cm-1五个谱带,按IDH1基因型分类拉曼光谱的正确率为89%。
  • 作者认为拉曼光谱简单、快速且安全,在临床相关原位诊断方面展现出很大前景。

核心结论

  • 拉曼光谱是一种简单、快速且安全的IDH1突变检测方法,在临床相关原位诊断方面展现出很大前景。

研究设计与样本

  • 研究纳入36例手术中获得的人脑胶质瘤样本,制备冰冻切片,用DNA测序评估IDH1突变,每例样本采集100条拉曼光谱。

主要发现

  • IDH1突变型胶质瘤中与DNA相关的光谱带强度增加,而与脂质分子振动相关的谱带显著降低。
  • IDH1突变型与IDH1野生型胶质瘤中与蛋白相关的拉曼谱带强度存在差异,提示蛋白谱改变。
  • 选取498、826、1003、1174和1337 cm-1五个谱带,可将拉曼光谱按IDH1基因型分类,正确率为89%。

关键数值与推荐

  • 选取498、826、1003、1174和1337 cm-1五个谱带进行分类,按IDH1基因型分类拉曼光谱的正确率为89%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Mutations in the isocytrate dehydrogenase 1 (IDH1) gene are early genetic events in glioma pathogenesis and cause profound metabolic changes. Because this genotype is found in virtually every tumor cell, therapies targeting mutant IDH1 protein are being developed. The intraoperative administration of those therapies would require fast technologies for the determination of IDH1 genotype. As of today, there is no such diagnostic test available. Recently, infrared spectroscopy was shown to bridge this gap. Here, we tested Raman spectroscopy for analysis of IDH1 genotype in glioma, which constitutes an alternative contact-free technique with the potential of being applicable in situ. METHODS: Human glioma samples (n = 36) were obtained during surgery and cryosections were prepared. IDH1 mutations were assessed using DNA sequencing and 100 Raman spectra were obtained for each sample. RESULTS: Analysis of Raman spectra revealed increased intensities in spectral bands related to DNA in IDH1 mutant glioma while bands assigned to molecular vibrations of lipids were significantly decreased. Moreover, intensities of Raman bands assigned to proteins differed in IDH1 mutant and IDH1 wild-type glioma, suggesting alterations in the protein profile. The selection of five bands (498, 826, 1003, 1174 and 1337 cm-1) allowed the classification of Raman spectra according to IDH1 genotype with a correct rate of 89%. CONCLUSION: Raman spectroscopy constitutes a simple, rapid and safe procedure for determination of the IDH1 mutation that shows great promise for clinically relevant in situ diagnostics.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Uckermann O, Yao W, Juratli TA, et al. IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy. J Neurooncol. 2018. PMID: 29761368. doi:10.1007/s11060-018-2883-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。